Page last updated: 2024-08-23

substance p and levodopa

substance p has been researched along with levodopa in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-199010 (35.71)18.7374
1990's10 (35.71)18.2507
2000's6 (21.43)29.6817
2010's2 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, H; Chihara, K; Iwasaki, J; Iwasaki, Y; Kato, Y1
Rinne, UK1
Abe, H; Chihara, K; Imur, H; Iwasaki, Y; Kato, Y; Ohgo, S1
De Ceballos, ML; Jenner, P; Marsden, CD; Rose, S; Taylor, MD1
Krause, JE; Sivam, SP1
Asanuma, M; Haba, K; Mori, A; Ogawa, N; Pongdhana, K; Sora, YH1
Chase, TN; Engber, TM; Gerfen, CR; Kuo, S; Susel, Z1
Persson, B; Rubenson, A; Sillén, U1
Rubenson, A; Sillén, U1
Gibb, JW; Hanson, GR; Sonsalla, PK1
Klawans, HL1
Abe, H; Chihara, K; Imura, H; Iwasaki, Y; Kato, Y1
Drujan, BD; Laufer, M; Negishi, K1
Rinne, UK; Tenovuo, O; Viljanen, MK1
Jenner, P; Jolkkonen, J; Marsden, CD1
Asanuma, M; Iwata, E; Kondo, Y; Matsuura, K; Nishibayashi, S; Ogawa, N1
Palmiter, RD; Zhou, QY1
Bordet, R; Carboni, S; Diaz, J; Ridray, S; Schwartz, JC; Sokoloff, P1
Drukarch, B; Stoof, JC; van de Witte, SV; Voorn, P1
Ahlenius, S; Ericson, E1
Damier, P; Féger, J; Hirsch, EC; Tremblay, L1
Andren, PE; Gunne, L; Svenningsson, P1
Arai, H; Ohrui, T; Sasaki, H; Yamaya, M; Yanai, M1
Fukuda, T; Iwata, S; Masuyama, T; Morioka, H; Nomoto, M; Shimizu, T1
Cheetham, S; Jenner, P; Lane, EL1
Andren, PE; Chergui, K; Svenningsson, P; Zhang, X1
Collier, TJ; Gebremedhin, KG; O'Malley, J; Paumier, KL; Rademacher, DJ; Sisson, KA; Sortwell, CE; Stancati, JA; Steece-Collier, K1
Ahn, S; Hong, S; Jang, J; Jeon, S; Jung, YR; Kim, J; Oh, JY; Park, HJ; Park, SU; Shin, HS; Song, MA; Song, TJ1

Reviews

4 review(s) available for substance p and levodopa

ArticleYear
Recent advances in research on Parkinsonism.
    Acta neurologica Scandinavica. Supplementum, 1978, Volume: 67

    Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase

1978
Chorea.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl

    Topics: Antipsychotic Agents; Cholinergic Fibers; Chorea; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Humans; Huntington Disease; Levodopa; Reserpine; Serotonin; Somatostatin; Substance P

1987
[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
    Revue neurologique, 2000, Volume: 156, Issue:3

    Topics: Animals; Antiparkinson Agents; Biological Transport, Active; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; Enkephalins; Haplorhini; Humans; Levodopa; Neural Pathways; Neuronal Plasticity; Neurons, Efferent; Parkinson Disease; Receptors, Dopamine D2; Substance P; Time Factors

2000
Interventions to prevent pneumonia among older adults.
    Journal of the American Geriatrics Society, 2001, Volume: 49, Issue:1

    Topics: Aged; Amantadine; Angiotensin-Converting Enzyme Inhibitors; Cerebrovascular Disorders; Gastroesophageal Reflux; Humans; Infection Control; Influenza Vaccines; Influenza, Human; Levodopa; Oral Hygiene; Pneumococcal Vaccines; Pneumonia; Pneumonia, Aspiration; Risk Factors; Substance P

2001

Other Studies

24 other study(ies) available for substance p and levodopa

ArticleYear
[Effects of biogenic amines and related neurotransmitter substances on the secretion of growth hormone].
    Horumon to rinsho. Clinical endocrinology, 1977, Volume: 25, Issue:3

    Topics: Animals; Biogenic Amines; Growth Hormone; Hypothalamus; Levodopa; Male; Neurotransmitter Agents; Rats; Substance P

1977
Growth hormone and prolactin release by substance P in rats.
    Life sciences, 1976, Aug-01, Volume: 19, Issue:3

    Topics: Animals; Growth Hormone; Hypothalamus; Levodopa; Male; Prolactin; Rats; Secretory Rate; Substance P

1976
Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    European journal of pharmacology, 1992, Aug-25, Volume: 219, Issue:2

    Topics: Animals; Carbidopa; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neuropeptides; Neurotensin; Oxidopamine; Prosencephalon; Rats; Rats, Wistar; Substance P; Substantia Nigra

1992
Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Blotting, Northern; Brain; Dopamine; Female; Injections, Intraperitoneal; Levodopa; Male; Phenylacetates; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; RNA, Messenger; Substance P; Tachykinins

1990
Alterations of somatostatin and its modulation by levodopa in MPTP-treated mouse brain.
    Journal of the neurological sciences, 1990, Volume: 100, Issue:1-2

    Topics: Animals; Brain Chemistry; Dopamine; Levodopa; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Norepinephrine; Sincalide; Somatostatin; Substance P; Thyrotropin-Releasing Hormone

1990
Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
    Brain research, 1991, Jun-21, Volume: 552, Issue:1

    Topics: Animals; Choline O-Acetyltransferase; Corpus Striatum; Drug Administration Schedule; Dynorphins; Enkephalins; Functional Laterality; Globus Pallidus; Glutamate Decarboxylase; Levodopa; Male; Oxidopamine; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra

1991
Central effects of baclofen on the L-dopa induced hyperactive urinary bladder of the rat.
    Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 330, Issue:3

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Baclofen; Bicuculline; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Injections, Intraventricular; Levodopa; Male; Naloxone; Rats; Rats, Inbred Strains; Substance P; Urinary Bladder

1985
Central and peripheral motor effects of morphine on the rat urinary bladder.
    Acta physiologica Scandinavica, 1986, Volume: 126, Issue:2

    Topics: Acetylcholine; Animals; Carbidopa; Dose-Response Relationship, Drug; Electric Stimulation; Injections, Intra-Arterial; Injections, Intraventricular; Levodopa; Male; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Pelvis; Rats; Rats, Inbred Strains; Substance P; Urinary Bladder

1986
Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
    Neuropharmacology, 1986, Volume: 25, Issue:11

    Topics: 5,7-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Corpus Striatum; Dopamine; Hydroxydopamines; Levodopa; Male; Methamphetamine; Methyltyrosines; Oxidopamine; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Synaptic Transmission; Tryptophan Hydroxylase

1986
Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1980, Volume: 165, Issue:2

    Topics: Animals; Chlorpromazine; Dopamine Antagonists; Growth Hormone; Haloperidol; Levodopa; Male; Pituitary Gland; Prolactin; Rats; Substance P

1980
Pharmacological manipulation of spatial properties of S-potentials.
    Vision research, 1981, Volume: 21, Issue:11

    Topics: Acetylcholine; Animals; Carbachol; Dopamine; Fishes; In Vitro Techniques; Levodopa; Membrane Potentials; Retina; Substance P

1981
Substance P immunoreactivity in the post-mortem parkinsonian brain.
    Brain research, 1984, Jun-11, Volume: 303, Issue:1

    Topics: Aged; Antipsychotic Agents; Brain Chemistry; Female; Humans; Levodopa; Male; Parkinson Disease; Putamen; Radioimmunoassay; Substance P; Substantia Nigra

1984
L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP.
    Brain research. Molecular brain research, 1995, Volume: 32, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Callithrix; Caudate Nucleus; Enkephalins; Female; Gene Expression; In Situ Hybridization; Levodopa; Male; Mazindol; Motor Activity; Nucleus Accumbens; Putamen; RNA, Messenger; Substance P

1995
Cholecystokinin alterations and effects of levodopa administration in the MPTP-treated mouse brain.
    Research communications in molecular pathology and pharmacology, 1995, Volume: 88, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Cholecystokinin; Dopamine; Levodopa; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neuropeptides; Radioimmunoassay; Substance P; Thyrotropin-Releasing Hormone

1995
Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic.
    Cell, 1995, Dec-29, Volume: 83, Issue:7

    Topics: Adrenergic Fibers; Animals; Animals, Newborn; Behavior, Animal; Dopamine; Dopamine beta-Hydroxylase; Drinking Behavior; Dynorphins; Embryo, Mammalian; Feeding Behavior; Immunohistochemistry; In Situ Hybridization; Levodopa; Mesencephalon; Mice; Mice, Transgenic; Mutation; Neostriatum; Neurons; Norepinephrine; Substance P; Transgenes; Tyrosine 3-Monooxygenase

1995
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Apr-01, Volume: 94, Issue:7

    Topics: Animals; Autoradiography; Behavior, Animal; Dynorphins; Gene Expression Regulation; In Situ Hybridization; Levodopa; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Substance P

1997
Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist.
    Brain research. Molecular brain research, 1998, Oct-30, Volume: 61, Issue:1-2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Corpus Striatum; Dynorphins; Injections, Intraperitoneal; Injections, Subcutaneous; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Stereotaxic Techniques; Substance P

1998
Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission.
    Brain research, 1999, Mar-20, Volume: 822, Issue:1-2

    Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Bradykinin; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Galanin; Hippocampus; Injections, Intraventricular; Levodopa; Locomotion; Male; Motor Activity; Neocortex; Neostriatum; Neural Inhibition; Nucleus Accumbens; Olfactory Bulb; Peptide Fragments; Rats; Rats, Wistar; Substance P; Synaptic Transmission; Ventral Tegmental Area

1999
L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
    Neuroscience, 2000, Volume: 99, Issue:3

    Topics: Animals; Benzazepines; Blotting, Western; Callithrix; Cerebral Cortex; Corpus Striatum; Denervation; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Antagonists; Enkephalins; Gene Expression; Genes, Immediate-Early; Levodopa; Nerve Degeneration; Oxidopamine; Parkinson Disease; Protein Precursors; Proto-Oncogene Proteins c-fos; Raclopride; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P; Substantia Nigra; Sympatholytics; Tritium

2000
Antinociceptive mechanism of L-DOPA.
    Pain, 2004, Volume: 110, Issue:1-2

    Topics: Animals; Behavior, Animal; Benserazide; Benzazepines; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Injections, Spinal; Levodopa; Male; Mice; Pain; Pain Measurement; Spinal Cord; Substance P; Time Factors

2004
Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.
    Journal of neural transmission (Vienna, Austria : 1996), 2008, Volume: 115, Issue:3

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Chlorobenzenes; Corpus Striatum; Cyclobutanes; Dynorphins; Enkephalins; Gene Expression; In Situ Hybridization; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; RNA, Messenger; Substance P; Time

2008
Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.
    Neuropharmacology, 2008, Volume: 54, Issue:7

    Topics: Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cocaine; Disease Models, Animal; Dopamine; Feedback; Functional Laterality; Gene Expression Regulation; Levodopa; Oxidopamine; Parkinson Disease; Peptide Fragments; Quinolines; Radioisotopes; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Serine; Substance P; Sympatholytics; Tyrosine 3-Monooxygenase

2008
Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration.
    Neurobiology of disease, 2015, Volume: 77

    Topics: Aging; Amphetamine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopaminergic Neurons; Dyskinesia, Drug-Induced; Embryo, Mammalian; Functional Laterality; Levodopa; Neurites; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred F344; Recovery of Function; Stem Cell Transplantation; Substance P

2015
Effects of a combination treatment of KD5040 and
    BMC complementary and alternative medicine, 2017, Apr-19, Volume: 17, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Enkephalins; Extracellular Signal-Regulated MAP Kinases; Levodopa; Magnoliopsida; Male; Mice, Inbred C57BL; Movement; Parkinson Disease; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-fos; Substance P

2017